Coronary Stents Market Analysis

ID: MRFR/MED/5473-HCR

130 Pages

Kinjoll Dey

October 2025

Coronary Stents Market Research Report By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents), By Material (Metal Stents, Polymer Stents, Coated Stents), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs), By Application (Coronary Artery Disease, Peripheral Artery Disease, Acute Myocardial Infarction) and By Regional (North America, Europe, South A...

Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Coronary Stents Market Industry Landscape

A vital area of the clinical gadget industry, the Coronary Stents Market is given to techniques used to treat coronary course illnesses. Stents are of basic significance in the rebuilding of myocardial blood stream and the relief of side effects connected to coronary circumstances. Expanding Worldwide Predominance of Cardiovascular Infections: The market elements are essentially influenced by the rising worldwide pervasiveness of cardiovascular sicknesses. An ascent in coronary confusions is brought about by maturing populaces, unfortunate ways of behaving, and changes in way of life, all of which increase the interest for viable arrangements like coronary stents.

Quick mechanical advances in the clinical field have achieved a critical change in the plans and materials of coronary stents. Patient results have been considerably improved through the execution of advancements, for example, drug-eluting stents (DES) and bioresorbable stents, which really moderate intricacies and advance the recuperation interaction. The cutthroat climate in the market is set apart by savage contention among critical industry members. Associations make significant interests in innovative work to present imaginative stents that show improved wellbeing and adequacy, bringing about a continuous stream of new items. Administrative System: To guarantee patient security, the creation and commercialization of coronary stents are dependent upon severe administrative guidelines. Guaranteeing adherence to administrative commitments, including FDA endorsements, is of vital significance for both entering the market and keeping an upper hand. Geological Varieties: Because of aberrations in illness predominance, financial elements, and medical services framework, market elements vary between districts. An expansion in medical services openness prompts a flood popular for coronary inserts in arising economies. There is a developing inclination among patients and medical services suppliers for negligibly intrusive techniques, and coronary stenting is predictable with this developing example. Because of the diminished recuperation time and diminished risk, stenting is turning into an undeniably famous system. The elements of the market are significantly affected by financial variables, which include medical services consumption and repayment strategies. The reasonableness of coronary stents fundamentally influences openness, subsequently raising the significance of medical services strategies as a deciding component. The market has seen the acquaintance of conventional options with coronary stents, which offer more conservative other options. As a result, evaluating techniques have been influenced by expanded rivalry among makers and further developed reasonableness for patients. Coordinated efforts and associations are instrumental in advancing development and the headway of cutting-edge coronary stent advancements. These cooperative endeavors and organizations lay out a structure for collaborations among industry members, makers, and exploration foundations. Patient Instruction and Mindfulness: Improved patient information in regard to cardiovascular wellbeing and the openness of creative treatment choices altogether impact market elements. Patient schooling drives work with mediation and early recognition.

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

FAQs

What was the market size of the Coronary Stents Market in 2024?

The Coronary Stents Market was valued at 6.62 USD Billion in 2024.

What is the projected market size for the Coronary Stents Market by 2035?

By 2035, the Coronary Stents Market is projected to reach a value of 9.2 USD Billion.

What is the expected CAGR for the Coronary Stents Market from 2025 to 2035?

The expected compound annual growth rate for the market from 2025 to 2035 is 3.04%.

Which region holds the largest market share for the Coronary Stents Market in 2024?

North America holds the largest market share, valued at 2.75 USD Billion in 2024.

How is the Asia Pacific region expected to grow in the Coronary Stents Market by 2035?

The Asia Pacific region is expected to grow to 2.08 USD Billion by 2035, up from 1.5 USD Billion in 2024.

What are the market values for Drug-Eluting Stents in 2024 and 2035?

The market value for Drug-Eluting Stents is 3.6 USD Billion in 2024 and is expected to rise to 4.6 USD Billion by 2035.

Which companies are considered major players in the Coronary Stents Market?

Major players include Boston Scientific Corporation, Medtronic PLC, and Abbott Laboratories, among others.

What is the expected market value for Bare-Metal Stents in 2035?

The expected market value for Bare-Metal Stents by 2035 is 2.9 USD Billion.

What challenges could impact the growth of the Coronary Stents Market?

Challenges may include regulatory hurdles and competition among established and emerging players.

What segment of the Coronary Stents Market is anticipated to grow the fastest?

The Bioabsorbable Stents segment is anticipated to show significant growth, expected to reach 1.7 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Coronary Stents Market Size was estimated at 6.62 USD Billion in 2024. The Coronary Stents industry is projected to grow from 6.821 USD Billion in 2025 to 9.203 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.04 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Coronary Stents Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

North America remains the largest market for coronary stents, driven by advanced healthcare infrastructure and high prevalence of cardiovascular diseases.
The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a growing geriatric population.
Drug-eluting stents dominate the market, while bare-metal stents are experiencing the fastest growth due to their cost-effectiveness and accessibility.
Key market drivers include the increasing prevalence of cardiovascular diseases and technological innovations in stent design, which are enhancing patient outcomes.

Coronary Stents Market

CAGR

3.04%

Market Size & Forecast

2024 Market Size	6.62 (USD Billion)
2035 Market Size	9.203 (USD Billion)
CAGR (2025 - 2035)	3.04%
Largest Regional Market Share in 2024	North America

Major Players

Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cardinal Health, Inc. (US), Johnson & Johnson (US), Cook Medical Incorporated (US)

Market Trends

The Coronary Stents Market is currently experiencing a dynamic evolution, driven by advancements in technology and increasing demand for minimally invasive procedures. The market appears to be influenced by a growing awareness of cardiovascular diseases, which has led to a rise in the number of patients seeking treatment options. Furthermore, the introduction of innovative stent designs, such as bioresorbable stents, suggests a shift towards more effective and safer solutions for patients. This trend indicates a potential for improved patient outcomes and a reduction in complications associated with traditional stents. In addition, the Coronary Stents Market seems to be benefiting from a surge in research and development activities. Companies are increasingly investing in the development of next-generation stents that incorporate advanced materials and drug-eluting technologies. This focus on innovation may enhance the efficacy of stents and address the limitations of existing products. Moreover, the expansion of healthcare infrastructure in emerging markets could further propel the growth of this sector, as access to advanced medical technologies becomes more widespread. Overall, the Coronary Stents Market is poised for continued growth, driven by technological advancements and an increasing emphasis on patient-centered care.

Technological Advancements

The Coronary Stents Market is witnessing a notable trend towards technological innovations. New materials and designs are being developed to enhance the performance and safety of stents. This evolution may lead to improved patient outcomes and a reduction in complications.

Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive procedures among patients and healthcare providers. This trend is likely to drive the adoption of coronary stents, as they offer effective treatment options with shorter recovery times and less discomfort.

Expansion in Emerging Markets

Emerging markets are experiencing an increase in healthcare investments, which may facilitate greater access to advanced medical technologies. This expansion could significantly impact the Coronary Stents Market, as more patients gain access to innovative treatment options.

The ongoing advancements in coronary stent technology, particularly in drug-eluting stents, appear to enhance patient outcomes and reduce the incidence of restenosis, suggesting a promising trajectory for the market.

U.S. Food and Drug Administration (FDA)

Coronary Stents Market Market Drivers

Rising Geriatric Population

The increasing geriatric population is a significant factor influencing the Coronary Stents Market. As individuals age, the risk of developing cardiovascular diseases escalates, leading to a higher demand for coronary interventions. The World Health Organization projects that the number of people aged 60 years and older will double by 2050, indicating a growing patient base for stenting procedures. This demographic shift necessitates the availability of effective treatment options, thereby driving the market for coronary stents. Additionally, healthcare systems are adapting to cater to the needs of older patients, which may include more frequent use of stents in clinical practice. Consequently, the Coronary Stents Market is likely to expand in response to this demographic trend.

Government Initiatives and Funding

Government initiatives aimed at improving cardiovascular health are playing a crucial role in the Coronary Stents Market. Many countries are implementing policies to enhance access to cardiovascular care, including funding for advanced medical technologies. These initiatives often focus on reducing healthcare costs associated with cardiovascular diseases, which can be substantial. By promoting the use of coronary stents as a cost-effective treatment option, governments are likely to stimulate market growth. Furthermore, public health campaigns aimed at raising awareness about heart health may lead to increased screening and early intervention, further driving demand for coronary stents. As a result, the Coronary Stents Market stands to benefit from supportive governmental policies and funding.

Technological Innovations in Stent Design

Technological advancements in stent design and materials are transforming the Coronary Stents Market. Innovations such as bioresorbable stents and drug-eluting stents are gaining traction due to their ability to reduce complications and improve patient outcomes. These advancements not only enhance the efficacy of stenting procedures but also address concerns related to long-term stent placement. The introduction of new materials that promote better biocompatibility and reduce restenosis rates is likely to attract more healthcare providers to adopt these technologies. As a result, the Coronary Stents Market is poised for growth, with manufacturers investing in research and development to create next-generation stents that meet evolving clinical needs.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases is a primary driver for the Coronary Stents Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options escalates. According to recent data, cardiovascular diseases account for a substantial percentage of global mortality rates, prompting healthcare systems to prioritize interventions. This trend is likely to fuel the adoption of coronary stents, as they are essential in treating blocked arteries. The Coronary Stents Market is expected to witness significant growth as healthcare providers seek to enhance patient outcomes through advanced stenting technologies. Furthermore, the increasing awareness of heart health among the general population may lead to earlier diagnoses and interventions, further propelling market expansion.

Growing Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures is significantly impacting the Coronary Stents Market. Patients increasingly favor treatments that offer quicker recovery times and reduced hospital stays. Coronary stenting, as a minimally invasive option, aligns with this trend, providing effective solutions for coronary artery disease without the need for extensive surgical interventions. The rise in patient awareness regarding the benefits of such procedures is likely to drive demand for coronary stents. Additionally, healthcare providers are adopting these techniques to enhance patient satisfaction and outcomes. As a result, the Coronary Stents Market is expected to experience robust growth, driven by the shift towards less invasive treatment modalities.

Market Segment Insights

By Type: Drug-Eluting Stents (Largest) vs. Bare-Metal Stents (Fastest-Growing)

In the Coronary Stents Market, Drug-Eluting Stents (DES) hold the largest share, dominating the market due to their ability to slowly release medication to prevent artery blockage. This category has consistently led the market as healthcare providers prefer stents that reduce the risk of restenosis. Bare-Metal Stents (BMS) represent a significant portion of the market as well, but their share is gradually decreasing as newer technologies become available. The patient preference for DES and growing awareness about advanced treatment options further solidify DES's market status.

Drug-Eluting Stents (Dominant) vs. Bioabsorbable Stents (Emerging)

Drug-Eluting Stents enjoy a dominant position in the market primarily because they minimize the chances of re-blockage in arteries by delivering drug therapy directly to the arterial wall during the healing process. This feature makes them highly favored among cardiologists and hospitals, leading to an increased adoption rate in various procedures. Conversely, Bioabsorbable Stents are emerging in the market, characterized by their capability to dissolve naturally within the body over time. They present a unique advantage by reducing long-term complications associated with permanent implants, capturing interest, especially among patients seeking less invasive solutions. While still gaining traction, their innovative technology positions them as a compelling alternative for future coronary interventions.

By Material: Metal Stents (Largest) vs. Coated Stents (Fastest-Growing)

In the Coronary Stents Market, Metal Stents hold a significant portion of the market share, benefiting from their robust structure and reliability in delivering long-term patient outcomes. The familiarity among healthcare professionals and established clinical evidence further bolster their prevalence in clinical settings. On the other hand, Coated Stents are gaining momentum, as they incorporate specialized coatings to enhance biocompatibility and reduce complications, leading to their increasing adoption in recent years.

Metal Stents (Dominant) vs. Polymer Stents (Emerging)

Metal Stents are considered the dominant players in the market due to their historical use and well-documented efficacy. Their design ensures structural integrity and consistent performance in the coronary arteries. In contrast, Polymer Stents are emerging as viable alternatives, focusing on reduced thrombogenicity and improved healing times. They are appealing to specialists looking for less invasive and more patient-friendly options. Although Polymer Stents currently represent a smaller market share, innovations in polymer technology are driving interest and investment in this segment, potentially leading to increased market capture as healthcare providers prioritize patient outcomes.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The coronary stents market has a diverse distribution among various end-use segments, with hospitals holding the largest market share. This establishment is favored for invasive procedures, equipped with advanced surgical technologies and experienced medical staff. In contrast, ambulatory surgical centers are witnessing a rapid increase in adoption, driven by advancements in minimally invasive techniques and the rising preference for outpatient procedures. Cardiac catheterization labs also play a critical role, focusing primarily on coronary interventions, but they represent a smaller fraction compared to hospitals and ASC.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals remain the dominant end-use segment in the coronary stents market, attributed to their comprehensive facilities and access to specialized healthcare professionals. These institutions often feature advanced cardiac care units, making them the preferred choice for complex cardiovascular procedures. On the other hand, ambulatory surgical centers are emerging as a swift alternative, increasingly sought after for their efficiency and convenience. The trend towards outpatient care is favoring ASCs, as they allow faster recovery times and lower costs. As healthcare systems evolve, both segments will continue to adapt, with hospitals focusing on innovation while ASCs expand their capabilities.

By Application: Coronary Artery Disease (Largest) vs. Peripheral Artery Disease (Fastest-Growing)

In the Coronary Stents Market, Coronary Artery Disease (CAD) remains the largest segment, dominating market share due to its prevalence and the high rate of associated interventions. The increasing incidence of CAD, compounded by lifestyle factors such as obesity and sedentary lifestyles, contributes significantly to the high demand for coronary stenting procedures. Following closely, Peripheral Artery Disease (PAD) has emerged as a fast-growing segment, driven by an aging population and rising awareness regarding the condition. Thus, PAD is gradually capturing a notable portion of the market, enhancing its visibility and importance within the cardiovascular treatment landscape.

Coronary Artery Disease (Dominant) vs. Peripheral Artery Disease (Emerging)

Coronary Artery Disease (CAD) constitutes the dominant segment in the Coronary Stents Market due to its high incidence and the crucial role of stents in treatment. Patients suffering from CAD frequently undergo percutaneous coronary interventions, necessitating the use of stents to restore optimal blood flow. On the other hand, Peripheral Artery Disease (PAD) is gaining traction as an emerging segment. The growing concern over PAD, especially among older demographics, is prompting healthcare providers to adopt improved stenting technologies, thus boosting market opportunities. Both segments showcase distinct characteristics; CAD is characterized by a well-established treatment protocol, while PAD is driven by evolving awareness and innovations in stent design.

Get more detailed insights about Coronary Stents Market Research Report - Global Forecast till 2035

Regional Insights

The Coronary Stents Market exhibits significant regional diversity, with North America leading the charge. In 2024, North America is expected to dominate with a valuation of 2.75 USD Billion, which is projected to grow to 3.63 USD Billion by 2035, reflecting its majority holding in the market due to advanced healthcare infrastructure and high demand for coronary interventions.

Europe follows closely, with a market value of 1.85 USD Billion in 2024, increasing to 2.47 USD Billion by 2035, driven by an aging population and rising prevalence of cardiovascular diseases. In the Asia Pacific region, the market is valued at 1.5 USD Billion in 2024 and is expected to reach 2.08 USD Billion by 2035.

This growth is fueled by increasing healthcare investments and improving access to medical technologies. South America, with a smaller market size of 0.4 USD Billion in 2024, will grow to 0.54 USD Billion by 2035, signifying a developing region with potential for future growth.

The Middle East and Africa represent the smallest share, with a market value of 0.12 USD Billion in 2024 and projected to increase to 0.18 USD Billion by 2035, challenging growth due to limited healthcare access in some areas. Collectively, these regions create a complex landscape for the Coronary Stents Market, influenced by varying economic, health, and social dynamics.

Coronary Stents Market Regional Insights

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Coronary Stents Market is characterized by a dynamic competitive landscape marked by innovation, strategic partnerships, and a diverse portfolio of products aimed at addressing the growing incidence of cardiovascular diseases.

As the prevalence of heart-related ailments rises globally, the demand for advanced coronary stents has surged, driving manufacturers to develop innovative and effective solutions. The market is influenced by factors such as technological advancements, regulatory approvals, and the ongoing quest for improved patient outcomes, which compel companies to engage in rigorous research and development.

Players in the market are also focusing on cost-effective solutions to meet the needs of healthcare providers and patients, enhancing competition and encouraging market growth.

Boston Scientific Corporation holds a prominent position in the Coronary Stents Market, leveraging its extensive experience and innovative product offerings. The company's strengths lie in its strong research and development capabilities, which allow for the continual introduction of advanced coronary stents that enhance procedural outcomes and minimize complications.

With a global operational footprint, Boston Scientific Corporation has a widespread market presence, supplying advanced solutions to diverse regions. The company’s commitment to innovation is reflected in its comprehensive product range, which includes both drug-eluting and bare-metal stents, catering to various hospital and outpatient settings.

Their focus on clinical evidence and partnerships with healthcare professionals further solidifies their leadership position in the market, making them a key player in the coronary stenting field.

Stentys is another noteworthy player in the Coronary Stents Market, primarily recognized for its innovative self-expanding stent technology designed to treat patients with acute myocardial infarction and other coronary conditions. The company emphasizes its commitment to providing effective solutions that improve patient outcomes and reduce complications associated with cardiovascular interventions.

Stentys has established a strategic market presence through collaborations and partnerships that enhance its distribution channels. The company's focus on research and development has led to a strong portfolio of products specifically tailored for various coronary conditions, further widening its market reach.

Stentys has also engaged in mergers and acquisitions to bolster its technological capabilities and expand its product offerings, positioning itself as a compelling alternative within the global landscape of coronary stenting solutions. Through these initiatives, Stentys aims to address the evolving challenges of healthcare providers and support the growing demand for innovative cardiovascular interventions.

Key Companies in the Coronary Stents Market market include

Industry Developments

Recent developments in the Coronary Stents Market have shown significant activity and progress, particularly with companies like Boston Scientific Corporation, Abbott Laboratories, and Medtronic PLC. In September 2023, Abbott Laboratories announced the launch of an advanced drug-eluting stent, enhancing treatment efficiency for patients with coronary artery disease.

Furthermore, Medtronic PLC has made strides in expanding its product offerings to reflect the growing demand for innovative stenting solutions. Current affairs indicate a continuous evolution in market dynamics, with an increasing emphasis on collaboration among key players.

Notably, in June 2023, Boston Scientific Corporation completed the acquisition of device maker BVS Medical, enhancing its portfolio in the coronary intervention space. The global market valuation for coronary stents is experiencing substantial growth, projected to surpass USD 6 billion by 2025, driven by rising incidences of cardiovascular diseases.

Additionally, regulatory shifts and increasing investment in Research and Development are optimizing product performance and patient outcomes. Over the last two years, the market has seen a pronounced shift towards minimally invasive heart procedures, and in March 2022, Terumo Corporation launched a cutting-edge hybrid stent technology, representing a leap in coronary intervention techniques.

Future Outlook

Coronary Stents Market Future Outlook

The Coronary Stents Market is projected to grow at a 3.04% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

Development of bioresorbable stents for enhanced patient outcomes.
Expansion into emerging markets with tailored product offerings.
Investment in telehealth solutions for remote patient monitoring post-stent placement.

By 2035, the market is expected to solidify its position as a critical component of cardiovascular care.

Market Segmentation

Coronary Stents Market Type Outlook

Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents

Coronary Stents Market End Use Outlook

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Labs

Coronary Stents Market Material Outlook

Metal Stents
Polymer Stents
Coated Stents

Coronary Stents Market Application Outlook

Coronary Artery Disease
Peripheral Artery Disease
Acute Myocardial Infarction

Report Scope

MARKET SIZE 2024	6.62(USD Billion)
MARKET SIZE 2025	6.821(USD Billion)
MARKET SIZE 2035	9.203(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.04% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Advancements in biodegradable stent technology enhance patient outcomes in the Coronary Stents Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the coronary stents market.
Countries Covered	North America, Europe, APAC, South America, MEA